Cardiomyopathy due to drug and external agent
- I42.7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2025 edition of ICD-10-CM I42.7 became effective on October 1, 2024.
- This is the American ICD-10-CM version of I42.7 – other international versions of ICD-10 I42.7 may differ.
Use Additional
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Code First
- poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
The following code(s) above I42.7 contain annotation back-references
that may be applicable to I42.7:
Approximate Synonyms
- Cardiomyopathy due to drug
- Dilated cardiomyopathy due to drug
- Dilated cardiomyopathy secondary to drug
- Dilated cardiomyopathy secondary to toxic reaction
- Drug induced cardiomyopathy
- Toxic cardiomyopathy
ICD-10-CM I42.7 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 314 Other circulatory system diagnoses with mcc
- 315 Other circulatory system diagnoses with cc
- 316 Other circulatory system diagnoses without cc/mcc
Convert I42.7 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Diagnosis Index entries containing back-references to I42.7:
- Cardiomyopathy (familial) (idiopathic) I42.9
- due to
- drugs I42.7
- external agents NEC I42.7
- toxic NEC I42.7
- due to
- Myocardiopathy (congestive) (constrictive) (familial) (hypertrophic nonobstructive) (idiopathic) (infiltrative) (obstructive) (primary) (restrictive) (sporadic) I42.9 – see also Cardiomyopathy
- toxic NEC I42.7